Skip to main content
. 2017 Jun 28;1(2):bjgpopen17X100977. doi: 10.3399/bjgpopen17X100977

Table 1. Patient demographics.

Characteristic Patients with TSH within reference range = 15, n (%) Patients with TSH lower than reference range = 7, n (%) Patients with TSH higher than reference range = 5, n (%)
Sex Female 11 (73) 4 (57) 3 (60)
Male 4 (27) 3 (43) 2 (40)
Location Rural 6 (40) 6 (86) 1 (20)
Urban 9 (60) 1 (14) 4 (80)
Age, years 30–39 1 (7) 1 (14) 2 (40)
40–49 1 (7) 1 (14) 1 (20)
50–59 0 (0) 0 (0) 1 (20)
60–69 8 (53) 3 (43) 1 (20)
70–79 3 (20) 1 (14) 0 (0)
80–89 2 (13) 1 (14) 0 (0)
Years with hypothyroidism ≤5 2 (13) 1 (14) 3 (60)
6–10 2 (13) 4 (57) 0 (0)
11–20 5 (33) 1 (14) 2 (40)
>20 6 (40) 1 (14) 0 (0)
Other relevant health conditions Coeliac disease 0 (0) 0 (0) 0 (0)
Pernicious anaemia 2 (13) 0 (0) 0 (0)
Gastrointestinal (gallstones/diverticulitis/irritable bowel syndrome/twisted bowel/constipation) 4 (27) 2 (29) 2 (40)
Type 2 diabetes 3 (20) 0 (0) 0 (0)
Other relevant medications Calcium-containing drugs 3 (20) 0 (0) 1 (20)
Iron-containing drugs 0 (0) 1 (14) 1 (20)
Proton pump inhibitors 3 (20) 1 (14) 1 (20)
BMI <20 1 (7) 0 0
20–25 5 (33) 1 (14) 2 (40)
26–30 5 (33) 5 (71) 2 (40)
31–35 3 (20) 1 (14) 1 (20)
36–40 1 (7) 0 0
Daily levothyroxine dose, µg 25 1 (7) 0 0
50 1 (7) 0 0
75 2 (13) 0 0
100 3 (20) 2 (29) 2 (40)
125 3 (20) 2 (29) 3 (60)
150 2 (13) 0 0
175 0 (0) 0 0
200 0 (0) 0 0
225 0 (0) 1 (14) 0
100/125 alternate day dosing 1 (7) 1 (14) 0
100/75 alternate day dosing 0 (0) 1 (14) 0
100 Monday–Friday, 75 Saturday–Sunday 2 (13) 0 0